Form 4 HUMANIGEN, INC For: Aug 11 Filed by: BLACK HORSE CAPITAL LP Aug 13, 2021 09:28PM
Form 4 HUMANIGEN, INC For: Jul 28 Filed by: BLACK HORSE CAPITAL LP Jul 30, 2021 09:02PM
Form 4 HUMANIGEN, INC For: Jul 21 Filed by: BLACK HORSE CAPITAL LP Jul 23, 2021 08:32PM
Form 4 HUMANIGEN, INC For: Jul 14 Filed by: BLACK HORSE CAPITAL LP Jul 16, 2021 08:28PM
Form 4 HUMANIGEN, INC For: Jul 08 Filed by: BLACK HORSE CAPITAL LP Jul 9, 2021 09:02PM
View Older Stories

Jul 2, 2021 05:44PM Form 4 HUMANIGEN, INC For: Jun 30 Filed by: BLACK HORSE CAPITAL LP
Jun 25, 2021 09:03PM Form 4 HUMANIGEN, INC For: Jun 23 Filed by: BLACK HORSE CAPITAL LP
Jun 21, 2021 08:57PM Form 4 HUMANIGEN, INC For: Jun 16 Filed by: BLACK HORSE CAPITAL LP
Jun 9, 2021 04:45PM Form 4 HUMANIGEN, INC For: Jun 07 Filed by: BLACK HORSE CAPITAL MANAGEMENT LLC
Jun 4, 2021 06:08PM Form 4 HUMANIGEN, INC For: Jun 02 Filed by: BLACK HORSE CAPITAL MANAGEMENT LLC
Feb 8, 2021 07:16AM Humanigen Inc. (HGEN) Reports Election of Dr. Dale Chappell to Board
May 31, 2019 08:32AM Kite (GILD) and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta With lenzilumab in R/R DLBCL
Apr 1, 2019 08:04AM Humanigen Inc. (HGEN) Highlights Prelim. Results from Ifabotuzumab Phase I Study at AACR Meetings
Jan 3, 2019 04:08PM Humanigen Inc. (HGEN) Reports Publication of New Research Demonstrating EphA3 Receptor as an Attractive Antibody Target for Brain Cancer & Other Solid Tumor Therapy
Mar 1, 2018 04:50PM Form SC 13D/A HUMANIGEN, INC Filed by: BLACK HORSE CAPITAL LP
Jan 26, 2018 05:16PM Form SC 13D/A HUMANIGEN, INC Filed by: BLACK HORSE CAPITAL LP
Jul 11, 2016 06:33PM Form 3 KALOBIOS PHARMACEUTICALS For: Jun 30 Filed by: BLACK HORSE CAPITAL LP
Jul 11, 2016 05:17PM Form SC 13D KALOBIOS PHARMACEUTICALS Filed by: BLACK HORSE CAPITAL LP
Jul 1, 2016 07:03AM KaloBios (KBIOQ) Completes Chapter 11 Bankruptcy; Acquires Benznidazole Development Rights
View Older Stories